{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:52:49Z","timestamp":1774957969362,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"MSD","award":["MISP # 61171"],"award-info":[{"award-number":["MISP # 61171"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-45900-8","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T07:24:57Z","timestamp":1774855497000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Attribute development for a discrete choice experiment to examine preferences for long-acting HIV prevention products among pregnant and breastfeeding women"],"prefix":"10.1038","volume":"16","author":[{"given":"Sophia M.","family":"Ngugi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Echoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Were","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Thuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vallery","family":"Ogello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryeve","family":"Gikwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Muteti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Mwangi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Kazungu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Ngure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"45900_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/infdis\/jiy118","volume":"218","author":"LM Mofenson","year":"2018","unstructured":"Mofenson, L. M. Risk of HIV acquisition during pregnancy and postpartum: A call for action. J. Infect. Dis. 218, 1\u20134 (2018).","journal-title":"J. Infect. Dis."},{"key":"45900_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001608","volume":"11","author":"AL Drake","year":"2014","unstructured":"Drake, A. L., Wagner, A., Richardson, B. & John-Stewart, G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: A systematic review and meta-analysis. PLoS Med. 11, e1001608 (2014).","journal-title":"PLoS Med."},{"key":"45900_CR3","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1097\/QAD.0b013e32834a9338","volume":"25","author":"NR Mugo","year":"2011","unstructured":"Mugo, N. R. et al. Increased risk of HIV-1 transmission in pregnancy: A prospective study among african HIV-1 serodiscordant couples. AIDS Lond. Engl. 25, 1887\u20131895 (2011).","journal-title":"AIDS Lond. Engl."},{"key":"45900_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/infdis\/jiy113","volume":"218","author":"KA Thomson","year":"2018","unstructured":"Thomson, K. A. et al. Increased risk of HIV acquisition among women throughout pregnancy and during the postpartum period: A prospective per-coital-act analysis among women with HIV-infected partners. J. Infect. Dis. 218, 16\u201325 (2018).","journal-title":"J. Infect. Dis."},{"key":"45900_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1933719108325510","volume":"16","author":"JS Sheffield","year":"2009","unstructured":"Sheffield, J. S., Wendel, G. D., McIntire, D. D. & Norgard, M. V. The effect of progesterone levels and pregnancy on HIV-1 coreceptor expression. Reprod. Sci. 16, 20\u201331 (2009).","journal-title":"Reprod. Sci."},{"key":"45900_CR6","doi-asserted-by":"publisher","DOI":"10.9745\/ghsp-d-22-00129","author":"SS Abadan","year":"2022","unstructured":"Abadan, S. S. et al. Preexposure prophylaxis among pregnant and lactating people in 18 PEPFAR-supported countries: A review of HIV strategies and guidelines. Global Health Sci. Pract. https:\/\/doi.org\/10.9745\/ghsp-d-22-00129 (2022).","journal-title":"Global Health Sci. Pract."},{"key":"45900_CR7","unstructured":"UNAIDS. The Path that Ends AIDS: UNAIDS Global AIDS Update 2023 (2023). https:\/\/thepath.unaids.org\/wp-content\/themes\/unaids2023\/assets\/files\/2023_report.pdf"},{"key":"45900_CR8","volume-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach (World Health Organization, 2016)."},{"key":"45900_CR9","unstructured":"PrEP Effectiveness | PrEP | HIV basics | HIV\/AIDS | CDC (2022). https:\/\/www.cdc.gov\/hiv\/basics\/prep\/prep-effectiveness.html"},{"key":"45900_CR10","doi-asserted-by":"publisher","first-page":"1221752","DOI":"10.3389\/frph.2023.1221752","volume":"5","author":"LJ Masenyetse","year":"2023","unstructured":"Masenyetse, L. J. et al. Oral HIV pre-exposure prophylaxis use among pregnant and postpartum women: Results from real-world implementation in Lesotho. Front. Reprod. Health 5, 1221752 (2023).","journal-title":"Front. Reprod. Health"},{"key":"45900_CR11","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/S2352-3018(22)00369-1","volume":"10","author":"D Moodley","year":"2023","unstructured":"Moodley, D. et al. Pregnancy and neonatal safety outcomes of timing of initiation of daily oral tenofovir disoproxil fumarate and emtricitabine pre-exposure prophylaxis for HIV prevention (CAP016): An open-label, randomised, non-inferiority trial. Lancet HIV 10, e154\u2013e163 (2023).","journal-title":"Lancet HIV"},{"key":"45900_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26044","volume":"25","author":"D Joseph Davey","year":"2022","unstructured":"Joseph Davey, D. et al. Adherence challenges with daily oral pre\u2010exposure prophylaxis during pregnancy and the postpartum period in South African women: A cohort study. J. Int. AIDS Soc. 25, e26044 (2022).","journal-title":"J. Int. AIDS Soc."},{"key":"45900_CR13","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1097\/QAD.0000000000003617","volume":"37","author":"J Pintye","year":"2023","unstructured":"Pintye, J. et al. HIV pre-exposure prophylaxis initiation, persistence, and adherence during pregnancy through the postpartum period. AIDS 37, 1725 (2023).","journal-title":"AIDS"},{"key":"45900_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1080\/17425247.2022.2135699","volume":"19","author":"V Agrahari","year":"2022","unstructured":"Agrahari, V. et al. Long-acting HIV pre-exposure prophylaxis (PrEP) approaches: Recent advances, emerging technologies, and development challenges. Expert Opin. Drug Deliv. 19, 1365\u20131380 (2022).","journal-title":"Expert Opin. Drug Deliv."},{"key":"45900_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002690","volume":"15","author":"RJ Landovitz","year":"2018","unstructured":"Landovitz, R. J. et al. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 15, e1002690 (2018).","journal-title":"PLoS Med."},{"key":"45900_CR16","doi-asserted-by":"publisher","first-page":"3913","DOI":"10.1128\/AAC.00656-15","volume":"59","author":"M Gunawardana","year":"2015","unstructured":"Gunawardana, M. et al. Pharmacokinetics of long-acting Tenofovir Alafenamide (GS-7340) subdermal implant for HIV prophylaxis. Antimicrob. Agents Chemother. 59, 3913\u20133919 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"45900_CR17","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","volume":"375","author":"A Nel","year":"2016","unstructured":"Nel, A. et al. Safety and efficacy of a Dapivirine vaginal ring for HIV prevention in women. N. Engl. J. Med. 375, 2133\u20132143 (2016).","journal-title":"N. Engl. J. Med."},{"key":"45900_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1097\/COH.0000000000000219","volume":"11","author":"RJ Landovitz","year":"2016","unstructured":"Landovitz, R. J., Kofron, R. & McCauley, M. The promise and pitfalls of long-acting injectable agents for HIV prevention. Curr. Opin. HIV AIDS 11, 122\u2013128 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"45900_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/QAD.0000000000002863","volume":"35","author":"T Morton","year":"2021","unstructured":"Morton, T. et al. Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioural science: NIH workshop directions. AIDS 35, 1313 (2021).","journal-title":"AIDS"},{"key":"45900_CR20","unstructured":"WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection. https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection"},{"key":"45900_CR21","unstructured":"FDA. FDA approves first injectable treatment for HIV pre-exposure prevention. FDA (2021). https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention"},{"key":"45900_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-023-02181-x","volume":"23","author":"EN Browne","year":"2023","unstructured":"Browne, E. N. et al. Incorporating end-users\u2019 voices into the development of an implant for HIV prevention: A discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health 23, 58 (2023).","journal-title":"BMC Womens Health"},{"key":"45900_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/bmj.328.7436.360","volume":"328","author":"M Ryan","year":"2004","unstructured":"Ryan, M. Discrete choice experiments in health care. BMJ 328, 360\u2013361 (2004).","journal-title":"BMJ"},{"key":"45900_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18256","volume":"9","author":"AS Alamri","year":"2023","unstructured":"Alamri, A. S., Georgiou, S. & Stylianou, S. Discrete choice experiments: An overview on constructing D-optimal and near-optimal choice sets. Heliyon 9, e18256 (2023).","journal-title":"Heliyon"},{"key":"45900_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/heapol\/czn047","volume":"24","author":"LJ Mangham","year":"2009","unstructured":"Mangham, L. J., Hanson, K. & McPake, B. How to do (or not to do) \u2026 Designing a discrete choice experiment for application in a low-income country. Health Policy Plan. 24, 151\u2013158 (2009).","journal-title":"Health Policy Plan."},{"key":"45900_CR26","unstructured":"Ryan, M. Using consumer preferences in health care decision making. The application of conjoint analysis. Off. Health Econ. (1996)."},{"key":"45900_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40273-018-0734-2","volume":"37","author":"V Soekhai","year":"2019","unstructured":"Soekhai, V., de Bekker-Grob, E. W., Ellis, A. R. & Vass, C. M. Discrete choice experiments in health economics: Past, present and future. Pharmacoeconomics 37, 201\u2013226 (2019).","journal-title":"Pharmacoeconomics"},{"key":"45900_CR28","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s40258-023-00794-9","volume":"21","author":"H Wang","year":"2023","unstructured":"Wang, H., Rowen, D. L., Brazier, J. E. & Jiang, L. Discrete choice experiments in health state valuation: A systematic review of progress and new trends. Appl. Health Econ. Health Policy 21, 405\u2013418 (2023).","journal-title":"Appl. Health Econ. Health Policy"},{"key":"45900_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/13696998.2022.2055937","volume":"25","author":"P Chiwire","year":"2022","unstructured":"Chiwire, P. et al. A discrete choice experiment investigating HIV testing preferences in South Africa. J. Med. Econ. 25, 481\u2013490 (2022).","journal-title":"J. Med. Econ."},{"key":"45900_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/14737167.2019.1530594","volume":"19","author":"BFM Wijnen","year":"2019","unstructured":"Wijnen, B. F. M. et al. A discrete choice experiment to investigate patient preferences for HIV testing programs in Bogot\u00e1, Colombia. Expert Rev. Pharmacoecon. Outcomes Res. 19, 195\u2013201 (2019).","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"45900_CR31","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/13696998.2020.1735398","volume":"23","author":"AJM Goossens","year":"2020","unstructured":"Goossens, A. J. M. et al. A discrete choice experiment to assess patients\u2019 preferences for HIV treatment in the rural population in Colombia. J. Med. Econ. 23, 803\u2013811 (2020).","journal-title":"J. Med. Econ."},{"key":"45900_CR32","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2147\/PPA.S405288","volume":"17","author":"S Fifer","year":"2023","unstructured":"Fifer, S., Kularatne, T., Tan, M., Drummond, F. & Rule, J. Understanding treatment preferences among people living with HIV in Australia: A discrete choice experiment. Patient Prefer. Adherence 17, 1825\u20131843 (2023).","journal-title":"Patient Prefer. Adherence"},{"key":"45900_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255650","volume":"16","author":"S Dommaraju","year":"2021","unstructured":"Dommaraju, S. et al. Preferences of people living with HIV for differentiated care models in Kenya: A discrete choice experiment. PLoS ONE 16, e0255650 (2021).","journal-title":"PLoS ONE"},{"key":"45900_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000614","volume":"2","author":"RO Mando","year":"2022","unstructured":"Mando, R. O. et al. Patient preferences for HIV service delivery models; a discrete choice experiment in Kisumu, Kenya. PLOS Glob. Public Health 2, e0000614 (2022).","journal-title":"PLOS Glob. Public Health"},{"key":"45900_CR35","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1186\/s12879-020-05399-4","volume":"20","author":"P Vickerman","year":"2020","unstructured":"Vickerman, P. et al. HIV prevention is not all about HIV\u2014using a discrete choice experiment among women to model how the uptake and effectiveness of HIV prevention products may also rely on pregnancy and STI protection. BMC Infect. Dis. 20, 704 (2020).","journal-title":"BMC Infect. Dis."},{"key":"45900_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1177\/0272989X17729376","volume":"38","author":"M Quaife","year":"2018","unstructured":"Quaife, M. et al. Divergent preferences for HIV prevention: A discrete choice experiment for multipurpose HIV prevention products in South Africa. Med. Decis. Making 38, 120\u2013133 (2018).","journal-title":"Med. Decis. Making"},{"key":"45900_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25528","volume":"23","author":"AM Minnis","year":"2020","unstructured":"Minnis, A. M. et al. Preferences for long\u2010acting pre\u2010exposure prophylaxis (PrEP) for HIV prevention among South African youth: Results of a discrete choice experiment. J. Int. AIDS Soc. 23, e25528 (2020).","journal-title":"J. Int. AIDS Soc."},{"key":"45900_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-069195","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Assessing preferences for HIV pre-exposure prophylaxis (PrEP) delivery services via online pharmacies in Kenya: Protocol for a discrete choice experiment. BMJ Open 13, e069195 (2023).","journal-title":"BMJ Open"},{"key":"45900_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10414-z","volume":"25","author":"V Ogello","year":"2025","unstructured":"Ogello, V. et al. Preferences for and acceptability of long-acting HIV prevention products among pregnant and lactating women accessing health services in Kenya: A mixed method cross-sectional analysis. BMC Infect. Dis. 25, 37 (2025).","journal-title":"BMC Infect. Dis."},{"key":"45900_CR40","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3109\/14659891.2015.1118563","volume":"21","author":"TM Helter","year":"2016","unstructured":"Helter, T. M. & Boehler, C. E. H. Developing attributes for discrete choice experiments in health: A systematic literature review and case study of alcohol misuse interventions. J. Subst. Use 21, 662\u2013668 (2016).","journal-title":"J. Subst. Use"},{"key":"45900_CR41","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong, A., Sainsbury, P. & Craig, J. Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 19, 349\u2013357 (2007).","journal-title":"Int. J. Qual. Health Care"},{"key":"45900_CR42","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hec.1739","volume":"21","author":"J Coast","year":"2012","unstructured":"Coast, J. et al. Using qualitative methods for attribute development for discrete choice experiments: Issues and recommendations. Health Econ. 21, 730\u2013741 (2012).","journal-title":"Health Econ."},{"key":"45900_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1177\/0272989X16683934","volume":"37","author":"C Vass","year":"2017","unstructured":"Vass, C., Rigby, D. & Payne, K. The role of qualitative research methods in discrete choice experiments. Med. Decis. Making 37, 298\u2013313 (2017).","journal-title":"Med. Decis. Making"},{"key":"45900_CR44","unstructured":"National AIDS and STI Control Programme. Kenya HIV Estimates Report, 2020 (2020)."},{"key":"45900_CR45","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"H-F Hsieh","year":"2005","unstructured":"Hsieh, H.-F. & Shannon, S. E. Three approaches to qualitative content analysis. Qual. Health Res. 15, 1277\u20131288 (2005).","journal-title":"Qual. Health Res."},{"key":"45900_CR46","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun, V. & Clarke, V. Using thematic analysis in psychology: Qualitative research in psychology. Qual. Res. Psychol. 3, 77\u2013101 (2006).","journal-title":"Qual. Res. Psychol."},{"key":"45900_CR47","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1524-4733.2009.00670.x","volume":"13","author":"EW de Bekker-Grob","year":"2010","unstructured":"de Bekker-Grob, E. W. et al. Labeled versus unlabeled discrete choice experiments in health economics: An application to colorectal cancer screening. Value Health 13, 315\u2013323 (2010).","journal-title":"Value Health"},{"key":"45900_CR48","doi-asserted-by":"publisher","DOI":"10.2196\/32365","volume":"23","author":"D Szinay","year":"2021","unstructured":"Szinay, D. et al. Understanding uptake of digital health products: Methodology tutorial for a discrete choice experiment using the bayesian efficient design. J. Med. Internet Res. 23, e32365 (2021).","journal-title":"J. Med. Internet Res."},{"key":"45900_CR49","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","volume":"8","author":"EW de Bekker-Grob","year":"2015","unstructured":"de Bekker-Grob, E. W., Donkers, B., Jonker, M. F. & Stolk, E. A. Sample size requirements for discrete-choice experiments in healthcare: A practical guide. Patient 8, 373\u2013384 (2015).","journal-title":"Patient"},{"key":"45900_CR50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4337\/9781800375635.00013","volume-title":"Handbook of Choice Modelling","author":"MCJ Bliemer","year":"2024","unstructured":"Bliemer, M. C. J. & Rose, J. M. Designing and conducting stated choice experiments. In Handbook of Choice Modelling (eds Hess, S. & Daly, A.) 172\u2013205 (Edward Elgar Publishing, 2024). https:\/\/doi.org\/10.4337\/9781800375635.00013."},{"key":"45900_CR51","unstructured":"ChoiceMetrics. https:\/\/www.choice-metrics.com\/"},{"key":"45900_CR52","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.19.1.20875","volume":"19","author":"EH Luecke","year":"2016","unstructured":"Luecke, E. H. et al. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J. Int. AIDS Soc. 19, 20875 (2016).","journal-title":"J. Int. AIDS Soc."},{"key":"45900_CR53","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/apc.2017.0075","volume":"31","author":"A van der Straten","year":"2017","unstructured":"van der Straten, A. et al. Favoring \u201cpeace of mind\u201d: A qualitative study of African women\u2019s HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial. AIDS Patient Care STDs 31, 305\u2013314 (2017).","journal-title":"AIDS Patient Care STDs"},{"key":"45900_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25626","volume":"23","author":"K Gill","year":"2020","unstructured":"Gill, K. et al. An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose). J. Int. AIDS Soc. 23, e25626 (2020).","journal-title":"J. Int. AIDS Soc."},{"key":"45900_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023272","volume":"9","author":"G Harling","year":"2019","unstructured":"Harling, G. et al. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: Cross-sectional survey. BMJ Open 9, e023272 (2019).","journal-title":"BMJ Open"},{"key":"45900_CR56","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","volume":"31","author":"ET Montgomery","year":"2017","unstructured":"Montgomery, E. T. et al. Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS Lond. Engl. 31, 1159\u20131167 (2017).","journal-title":"AIDS Lond. Engl."},{"key":"45900_CR57","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1007\/s10461-022-03658-w","volume":"26","author":"KM Little","year":"2022","unstructured":"Little, K. M. et al. HIV pre-exposure prophylaxis implant stated preferences and priorities: Results of a discrete choice experiment among women and adolescent girls in Gauteng Province, South Africa. AIDS Behav. 26, 3099\u20133109 (2022).","journal-title":"AIDS Behav."},{"key":"45900_CR58","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26088","volume":"26","author":"NJ Wara","year":"2023","unstructured":"Wara, N. J. et al. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya. J. Int. AIDS Soc. 26, e26088 (2023).","journal-title":"J. Int. AIDS Soc."},{"key":"45900_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-058611","volume":"12","author":"SW Beckham","year":"2022","unstructured":"Beckham, S. W. et al. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: A mixed-methods study. BMJ Open 12, e058611 (2022).","journal-title":"BMJ Open"},{"key":"45900_CR60","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-023-04202-0","author":"KM Little","year":"2023","unstructured":"Little, K. M. et al. Preferences for long-acting PrEP products among women and girls: A quantitative survey and discrete choice experiment in Eswatini, Kenya, and South Africa. AIDS Behav. https:\/\/doi.org\/10.1007\/s10461-023-04202-0 (2023).","journal-title":"AIDS Behav."},{"key":"45900_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0000981","volume":"2","author":"A Mantsios","year":"2022","unstructured":"Mantsios, A. et al. \u201cShe is the one who knows\u201d: A qualitative exploration of oral and injectable PrEP as part of a community empowerment approach to HIV prevention among female sex workers in the Dominican Republic and Tanzania. PLOS Glob. Public Health 2, e0000981 (2022).","journal-title":"PLOS Glob. Public Health"},{"key":"45900_CR62","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12879-022-07907-0","volume":"22","author":"MS Brown","year":"2022","unstructured":"Brown, M. S. et al. End-user research in support of long-acting systemic antiretroviral delivery systems: Insights from qualitative research with providers and target users in South Africa. BMC Infect. Dis. 22, 919 (2022).","journal-title":"BMC Infect. Dis."},{"key":"45900_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16955-3","volume":"23","author":"L Fynn","year":"2023","unstructured":"Fynn, L. et al. \u201cIt\u2019s already in your body and it\u2019s preventing\u201d: A qualitative study of African female adolescent\u2019s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. BMC Public Health 23, 2143 (2023).","journal-title":"BMC Public Health"},{"key":"45900_CR64","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jval.2023.01.002","volume":"26","author":"Z F\u00f6hn","year":"2023","unstructured":"F\u00f6hn, Z., Nicolet, A., Marti, J., Kaufmann, C. & Balthasar, A. Stakeholder engagement in designing attributes for a discrete choice experiment with policy implications: An example of 2 Swiss studies on healthcare delivery. Value Health 26, 925\u2013933 (2023).","journal-title":"Value Health"},{"key":"45900_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3305-5","author":"A De Br\u00fan","year":"2018","unstructured":"De Br\u00fan, A. et al. A novel design process for selection of attributes for inclusion in discrete choice experiments: Case study exploring variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke. BMC Health Serv. Res. https:\/\/doi.org\/10.1186\/s12913-018-3305-5 (2018).","journal-title":"BMC Health Serv. Res."},{"key":"45900_CR66","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1007\/s10461-019-02418-7","volume":"23","author":"MO Kuteesa","year":"2019","unstructured":"Kuteesa, M. O. et al. Acceptability and predictors of uptake of ati-retroviral pre-exposure prophylaxis (PrEP) among fishing communities in Uganda: A cross-sectional discrete choice experiment survey. AIDS Behav. 23, 2674\u20132686 (2019).","journal-title":"AIDS Behav."},{"key":"45900_CR67","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s10461-019-02715-1","volume":"24","author":"EN Browne","year":"2020","unstructured":"Browne, E. N. et al. Efficacy is not everything: Eliciting women\u2019s preferences for a vaginal HIV prevention product using a discrete-choice experiment. AIDS Behav. 24, 1443\u20131451 (2020).","journal-title":"AIDS Behav."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45900-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45900-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:02:44Z","timestamp":1774954964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-45900-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["45900"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-45900-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"30 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Approval to conduct the study was granted by the KEMRI Scientific and Ethics Review Unit (KEMRI\/SERU\/CPHR\/49\/4647), and written consent was obtained from all study participants before data collection. Further, permission to conduct the study was obtained from the National Commission for Science, Technology and Innovation, Kenya.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"10576"}}